injections of FVIII or FVIIICPI (10?IU/injection) were administered to female hemophilia A mice (test and one-way ANOVA followed by Dunnets post hoc multiple comparison test. that protects FVIII from degradation circulation time and reduced catabolism of FVIII in hemophilia A mice. FVIIICPI complex reduced inhibitor development in hemophilia A mice Continue Reading